AC
AGN

Andromeda Capital’s Allergan Inc AGN Stock Holding History

Andromeda Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-183,900
Closed -$32.8M – 359
2014
Q3 		$32.8M Buy
183,900
+52,300
+40% +$8.69M 1.93% 9
2014
Q2 		$22.3M Buy
+131,600
New +$20.5M 1.56% 20

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Andromeda Capital's AGN Position: Q1 2015 in Review

Andromeda Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 22,025 shares — an estimated $4.68M sold.

Andromeda Capital first reported a position in AGN in Q4 2014 and held it in 1 quarter. The position peaked at $4.68M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Andromeda Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Andromeda Capital sold 22,025 Allergan Inc shares in Q1 2015, an estimated $4.68M.
  • Andromeda Capital first reported a position in Allergan Inc in Q4 2014 and held it in 1 quarter.
  • Andromeda Capital's Allergan Inc position peaked at $4.68M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Andromeda Capital's 13F filing for Q1 2015, filed 15 May 2015.